Digital Pathology Software to Improve Breast Cancer Diagnosis and Ther
- 22/05/2012
Its reliance on biomarker evaluation for diagnosis and treatment decisions makes breast cancer care a good example of personalised medicine. In addition to breast cancer biomarkers such as the oestrogen/progesterone receptor and the Ki-67 proliferation marker, HER2 (Human Epidermal growth factor Receptor 2) has received particular attention in the recent years. 20 - 30 percent of women with breast...
READ MORE